Jeff Douglas

SVP, Development Operations at Alumis

Jeff Douglas is vice president of clinical operations at Alumis and brings more than 25 years of clinical research and development experience. Jeff joins Alumis from MyoKardia, where he served as head of clinical operations. Most recently, he successfully led the global development operations transition and integration with Bristol Myers Squibb. Prior to his tenure at MyoKardia, Jeff was the program director of Genentech’s research and development clinical operations where he oversaw programs focused on cancer immunotherapy and hematologic malignancies and helped to lead more than 30 compounds through preclinical development into late stage development. Jeff began his career as a practicing pharmacist after graduating with a Doctor of Pharmacy degree from the University of Missouri, Kansas City.

Timeline

  • SVP, Development Operations

    Current role

  • VP, Clinical Operations

View in org chart